@article {Skovlund2021.05.25.21254504, author = {Sandra Skovlund and Shelagh Cofer and Heather Weinreich}, title = {Feasibility of an Innovative Absorbable Ventilation Tube Designed to Provide Intermediate-Term Middle Ear Ventilation}, elocation-id = {2021.05.25.21254504}, year = {2021}, doi = {10.1101/2021.05.25.21254504}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Myringotomy with ventilation tube placement is a common surgical procedure performed in children and adults to remove fluid build-up behind the tympanic membrane. However, retention of tubes beyond achievement of therapeutic response increases risk for complications and additional intervention. This small feasibility study was conducted to demonstrate proof-of-concept of a novel bioabsorbable ventilation tube that provides the necessary duration of ventilation with absorption shortly thereafter in humans. Tubes were placed in 15 ears of 14 patients meeting indications for short or intermediate-duration of middle ear ventilation. Two independent examiners documented tube patency and tube absorption status at 3, 6 and 12 weeks or until absorption was complete. Results indicate that average ventilation time was 12 weeks (range 3 weeks to 18 months). There was no observation of blockage. These findings support the feasibility of a novel bioabsorbable ventilation tube.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04902963Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Park Nicollet Institute Institutional Review Board 3800 Park Nicollet Blvd., 5 North Minneapolis, MN 55416All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData regarding device status and functionality is available as documented.}, URL = {https://www.medrxiv.org/content/early/2021/05/27/2021.05.25.21254504}, eprint = {https://www.medrxiv.org/content/early/2021/05/27/2021.05.25.21254504.full.pdf}, journal = {medRxiv} }